Form 4: Phillip Frost and Frost Gamma Investments Trust Report Changes in OPKO Health Beneficial Ownership
SEC Form 4 Filing
Phillip Frost, along with Frost Gamma Investments Trust, reports changes in beneficial ownership of OPKO Health, Inc. securities, including convertible notes and common stock.
Summary
- Phillip Frost, in his capacity as Director, CEO & Chairman of OPKO Health, Inc., and Frost Gamma Investments Trust have filed a Form 4.
- The filing reports transactions related to 3.75% Convertible Notes due 2029 and common stock.
- On September 27, 2024, Convertible Notes were transacted at a price of $1.15, with $1,845,000 acquired.
- The notes are convertible into 1,604,347 shares of common stock at a conversion price of $1.15, and mature on January 15, 2029.
- The filing also indicates beneficial ownership of 35,308,000 shares of common stock held by Frost Gamma Investments Trust.
- Phillip Frost disclaims beneficial ownership of these securities except to the extent of any pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions and ownership details.
Future Outlook
The document does not contain explicit forward-looking statements beyond the terms of the convertible notes.
Management Comments
- Phillip Frost disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust, except to the extent of any pecuniary interest.
Industry Context
This filing is a routine disclosure related to insider transactions and significant ownership positions, common in publicly traded companies. It provides transparency to the market regarding the actions of key company figures and major shareholders.
Comparison to Industry Standards
- Form 4 filings are standard practice for reporting changes in beneficial ownership as mandated by the SEC.
- The details provided, such as transaction dates, amounts, and security types, are consistent with the required information for such filings.
- Comparable companies would have similar filings when their executives or major shareholders trade company stock or related securities.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- It informs stakeholders about the ownership structure and potential influence of major shareholders like Phillip Frost and Frost Gamma Investments Trust.
Key Dates
| Date | Description |
|---|---|
| January 9, 2024 | Date of Indenture for the 3.75% Convertible Senior Notes due 2029. |
| September 15, 2028 | Date after which holders of the Convertible Notes can convert such notes at the option of the holder. |
| January 15, 2029 | Maturity date of the 3.75% Convertible Senior Notes. |
| September 27, 2024 | Date of the reported transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.